top of page
a-q6Bltj_400x400.png.webp

Athena on Boards | Cohort 11

February - June 2023 | POWERED BY DLA PIPER

LESLIE BEST

VP, New Product Development, R/D Engineering

In Transition

SAMANTHA BISHOP

Director of Quality

Bionano Genomics

CARRIE CRAIG

Sr Director of Global Application Delivery

Bose

RAYNA HERMAN

Chief Commercial Officer

EVERSANA

MARGIE HOLMES

Sr Director, Regulatory Affairs

Mirati Therapeutics

HEATHER HUGHES

Sr. Manager, Customer Engagement Programs, NA Cloud Engineering

Oracle

ADRIANA MANZI

President

Atheln

VALARIE MOLAISON

Director, Federal Government Affairs

Neurocrine Biosciences

KELLIN NICOLETTI

VP, Legal Affairs

Dexcom

GOTHAMI PADMABANDU

Sr Director Assay Development

Verogen

BETH RITCHIE

Principal

The House Counsel, APC

QIAN RUAN

VP, TechOps & Supply Chain

Arcturus Therapeutics

KATHRYN STEPHENS

VP, R&D

Verogen

TIFFANY VALENTINE

Assoc Dir, Clinical Evolution

BMS

SRILAKSHMI VISHNUBHOTLA

Sr Manager, PM Public Health & Emerging Markets

Thermo Fisher Scientific

Contact Athena CEO, Holly Smithson to secure your spot on the waitlist

for the next cohort and design your board search through Athena’s On Board Series.

Athena on Boards | Mentors

AMY ANUK

Limited Partner

Beyond Capital Ventures

PENNY MINNA

Partner, Corporate & Securities Group

DLA Piper

ROBIN SEGERDAHL

Certified Leadership, Career & Group Coach, and Talent Consultant​

​

Athena on Boards Committee

JAYE CONNOLLY-LABELLE

CEO

RippleNami Inc.

CHARITY WILLIAMS

Partner

Cooley

GRACE CHUI-MILLER

Chief Financial Officer

Correlation Ventures

BO MONACO

Audit Partner

BDO

bottom of page